iTeos Therapeutics - ITOS Sotuvning sof marjinal rentabelligi

iTeos Therapeutics Inc (ITOS) grafik logotipi

iTeos Therapeutics (ITOS) kapitalni himoya qilish uchun GSK bilan tuzgan ittifoqidan foydalangan holda, saratonni davolashning ilg'or usullarini ishlab chiqmoqda. Tijorat sof marjasi ushbu bosqichning dinamikasini aks ettiradi, bunda 0.00 qiymati joriy ko'rsatkich bo'lib xizmat qiladi. O'sish TIGIT ingibitorlari va qattiq o'smalar bo'yicha tadqiqotlar hisobiga ta'minlanmoqda, moliyaviy baza esa hamkorlik avanslariga asoslangan, chunki mahsulotlarning bozor narxlari hali aniqlanmagan.

iTeos Therapeutics (ITOS) Sof marja: 04.07.2022 - 14.09.2025 davri uchun

iTeos Therapeutics (ITOS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:iTeos Therapeutics, Inc. - ITOS
iTeos Pharma tayyor mahsulotlari

Sof foyda marjasi barcha operatsion va soliq xarajatlarini qoplagandan keyin qolgan foyda ulushini belgilaydi. iTeos Therapeutics (ITOS) uchun ushbu ko'rsatkich laboratoriyalarning ekologik modernizatsiyasi bilan bog'liq xarajatlar fonida kapitalni boshqarish samaradorligini aks ettiradi. Kompaniyaning sof marjasini tahlil qilish ESG standartlarining yakuniy daromadlilikka ta'sirini baholash imkonini beradi. Bu yerda manfiy qiymatlar biotexnologiya sektori uchun odatiy holdir. Investorlar uchun biznesni kengaytirish signalini aniqlash maqsadida zararlarning kamayish tendentsiyasini kuzatish juda muhimdir.

iTeos Therapeutics kimlar bilan raqobatlashadi

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi Akari Therapeutics plc|Sof marja enlivex.com|q32bio.com (QTTB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi GOVX|Edesa Biotech, Inc. - Sotuvning sof rentabelligi|iBio Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Carisma Therapeutics CARM|XTLB - Sof marja|BOLT (boltbio.com) - Sotuvning sof rentabelligi|HCWB: Sotuvning sof marjinal rentabelligi|Aptevo (APVO) - Sotuvning sof marjinal rentabelligi|Sof marja AIM ImmunoTech|Sof foyda bo'yicha sotuv rentabelligi Aditxt (ADTX)|Sof foyda bo'yicha sotuv rentabelligi GRI (GRI Bio Corporation)|XORTX - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi HIND (Vyome Holdings Inc.)|Sof foyda normasi REVB|Indaptus - Sotuvning sof marjinal rentabelligi|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning sof rentabelligi|CALI: Sotuvning sof marjinal rentabelligi|Affimed NV - Sof foyda normasi|Sof marja Allakos Inc.|Sotuvning sof marjinal rentabelligi HOOKIPA Pharma|Sof marja IGM Biosciences, Inc. (IGMS)|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi